Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F05%3A00007603" target="_blank" >RIV/00023736:_____/05:00007603 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia

Original language description

In this randomized phase III study of the EORTC Leukemia Cooperative Group, treatemet of patients with myelodysplastic syndromes (MDS) with 10-30% bone marrow blasts and hematopoietic failure is analyzed.

Czech name

Léčba pomocí nízkých dávek cytosinu arabinoside (LD-AraC) vs LD-AraC plus granulocytů / makrofágů vs LD-AraC plus interleukinu-3 u MDS u pacientů s vysokým rizikem vývoje akutní leukémie.

Czech description

V této randomizované studii III skupiny EORTC Leukemia Cooperative Group je analyzováno léčení pacientů s MDS s poruchou krvetvorby v 10-30%.

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2005

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Leukemia

ISSN

0887-6924

e-ISSN

—

Volume of the periodical

19

Issue of the periodical within the volume

11

Country of publishing house

GB - UNITED KINGDOM

Number of pages

5

Pages from-to

—

UT code for WoS article

000232833100010

EID of the result in the Scopus database

—